Purple Biotech (Israel) Probability of Future Stock Price Finishing Under 0.04
| KTOV Stock | ILA 4.40 0.40 8.33% |
Purple |
Purple Biotech Target Price Odds to finish below 0.04
The tendency of Purple Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to 0.04 or more in 90 days |
| 4.40 | 90 days | 0.04 | near 1 |
Based on a normal probability distribution, the odds of Purple Biotech to drop to 0.04 or more in 90 days from now is near 1 (This Purple Biotech probability density function shows the probability of Purple Stock to fall within a particular range of prices over 90 days) . Probability of Purple Biotech price to stay between 0.04 and its current price of 4.4 at the end of the 90-day period is under 4.
Assuming the 90 days trading horizon Purple Biotech has a beta of 0.16. This indicates as returns on the market go up, Purple Biotech average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Purple Biotech will be expected to be much smaller as well. Additionally Purple Biotech has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Purple Biotech Price Density |
| Price |
Predictive Modules for Purple Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Purple Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Purple Biotech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Purple Biotech is not an exception. The market had few large corrections towards the Purple Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Purple Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Purple Biotech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.7 | |
β | Beta against Dow Jones | 0.16 | |
σ | Overall volatility | 4.08 | |
Ir | Information ratio | -0.37 |
Purple Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Purple Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Purple Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Purple Biotech generated a negative expected return over the last 90 days | |
| Purple Biotech has high historical volatility and very poor performance | |
| Purple Biotech has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 1000 K. Net Loss for the year was (5.85 M) with profit before overhead, payroll, taxes, and interest of 1000 K. | |
| Purple Biotech has accumulated about 63.01 M in cash with (5.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.4. |
Purple Biotech Technical Analysis
Purple Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. Purple Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Purple Biotech. In general, you should focus on analyzing Purple Stock price patterns and their correlations with different microeconomic environments and drivers.
Purple Biotech Predictive Forecast Models
Purple Biotech's time-series forecasting models is one of many Purple Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Purple Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Purple Biotech
Checking the ongoing alerts about Purple Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Purple Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Purple Biotech generated a negative expected return over the last 90 days | |
| Purple Biotech has high historical volatility and very poor performance | |
| Purple Biotech has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 1000 K. Net Loss for the year was (5.85 M) with profit before overhead, payroll, taxes, and interest of 1000 K. | |
| Purple Biotech has accumulated about 63.01 M in cash with (5.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.4. |
Additional Information and Resources on Investing in Purple Stock
When determining whether Purple Biotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Purple Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Purple Biotech Stock. Highlighted below are key reports to facilitate an investment decision about Purple Biotech Stock:Check out Purple Biotech Backtesting, Purple Biotech Valuation, Purple Biotech Correlation, Purple Biotech Hype Analysis, Purple Biotech Volatility, Purple Biotech History as well as Purple Biotech Performance. For information on how to trade Purple Stock refer to our How to Trade Purple Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.